Effect of statins on atherogenic serum amyloid A and α1-antitrypsin low-density lipoprotein complexes
详细信息 查看全文
- 作者：Yusuke Miyazakia ; c ; Yasufumi Katanasakaa ; b ; c ; Yoichi Sunagawaa ; b ; c ; Sae Hirano-Sunagawaa ; d ; Masafumi Funamotoa ; c ; Eriko Morimotob ; Maki Komiyamac ; Akira Shimatsuc ; Noriko Satoh-Asaharac ; Hajime Yamakagec ; Hiromichi Wadac ; Koji Hasegawac ; Tatsuya Morimotoa ; b ; c ; morimoto@u-shizuoka-ken.ac.jp" class="auth_mail" title="E-mail the corresponding author
- 关键词：SAA-LDL ; AT-LDL ; Statins ; Rosuvastatin ; Pitavastatin ; Dyslipidemia
- 刊名：International Journal of Cardiology
- 出版年：2016
- 出版时间：15 December 2016
- 年：2016
- 卷：225
- 期：Complete
- 页码：332-336
- 全文大小：224 K
文摘
- •
Oxidatively-modified LDLs are a known cardiovascular risk marker.
- •
Both rosuvastatin and pitavastatin decreased oxidatively-modified LDL levels.
- •
In both statin groups, change in oxidatively-modified LDL level was correlated with that in CRP.
- •
In the pitavastatin group, change in HbA1c level was correlated with that in serum amyloid A-LDL level.